Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.75 USD | -1.26% | -2.90% | -24.07% |
May. 23 | Some of the biggest splits in Corporate America | RE |
May. 20 | AdvanSix CFO Michael Preston to Retire | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.07% | 610M | C+ | ||
+0.88% | 48.63B | A- | ||
+21.10% | 42.74B | B+ | ||
+26.01% | 27.7B | A- | ||
+9.54% | 19.15B | C+ | ||
-2.65% | 16.52B | B+ | ||
+7.54% | 16.29B | B+ | ||
-25.63% | 15.21B | A- | ||
-11.57% | 15.02B | C+ | ||
-17.62% | 14.17B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ASIX Stock
- Ratings AdvanSix Inc.